Capricor Therapeutics | CAPR - Nettoeinkommen

Aktienkurs
30.10
Täglich Wechseln
1.00 3.44%
Monatlich
7.85%
Jährlich
126.66%
Q1 Prognose
28.23




Nettoeinkommen Veränderung Datum
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Bioline Rx USD -977K 2.96M 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Geron USD -31.14M 12.72M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -24.37M 2.99M 2024-09
J&J USD 5.12B 36M 2025-12
Prothena USD -21.59M 14.95M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12